Jaguar Health (JAGX) Net Cash Flow (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Net Cash Flow of $2.2 million for Q1 2026, up 194.34% year-over-year from $752542.3 in Q1 2025, and down 48.67% quarter-over-quarter from $4.3 million in Q4 2025.
Jaguar Health (JAGX) Net Cash Flow (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Net Cash Flow for 13 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow rose 194.34% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $4.6 million (up 176.43% YoY), while the FY2025 annual figure was -$57000.0, down 103.59% from the prior year.
- Net Cash Flow fell to $2.2 million in Q1 2026 per JAGX's latest filing, from $4.3 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $8.9 million in Q1 2023 and bottomed at -$7.2 million in Q2 2022.
- Historically, Net Cash Flow has averaged -$325882.4 across 5 years, with a median of $455000.0 in 2022.
- Annual changes were most pronounced in 2022 — Net Cash Flow sank 2071.99% — and 2023, when it soared 1848.57%.
- Jaguar Health's Net Cash Flow stood at -$5.1 million in 2022, then surged by 162.16% to $3.2 million in 2023, then sank by 262.89% to -$5.2 million in 2024, then jumped by 182.81% to $4.3 million in 2025, then plunged by 48.67% to $2.2 million in 2026.
- Business Quant data shows JAGX's Net Cash Flow at $2.2 million in Q1 2026, $4.3 million in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn | 2.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.22 Mn |
| Mar 31, 2026 | 2.22 Mn |
| Dec 31, 2025 | 4.32 Mn |
| Dec 31, 2025 | 4.32 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | -3.54 Mn |
| Jun 30, 2025 | -3.54 Mn |
| Mar 31, 2025 | -2.35 Mn |
| Mar 31, 2025 | -2.35 Mn |
| Dec 31, 2024 | -5.21 Mn |
| Dec 31, 2024 | -5.21 Mn |
| Sep 30, 2024 | -2.81 Mn |
| Sep 30, 2024 | -2.81 Mn |
| Jun 30, 2024 | 4.40 Mn |
| Jun 30, 2024 | 4.40 Mn |
| Mar 31, 2024 | 5.22 Mn |
| Mar 31, 2024 | 5.22 Mn |
| Dec 31, 2023 | 3.20 Mn |
| Dec 31, 2023 | 3.20 Mn |